Zhejiang Ausun Pharmaceutical Co Ltd (603229) — Capital Reinvestment Ratio
Zhejiang Ausun Pharmaceutical Co Ltd (603229) has a Capital Reinvestment Ratio of 0.23x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥121.49 Million) in capital expenditures (CN¥27.68 Million). See 603229 net asset quality score to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Zhejiang Ausun Pharmaceutical Co Ltd Capital Reinvestment Ratio (2013–2025)
This chart tracks Zhejiang Ausun Pharmaceutical Co Ltd's Capital Reinvestment Ratio across 13 annual periods. Check 603229 cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Zhejiang Ausun Pharmaceutical Co Ltd (2013–2025)
Year-by-year Capital Reinvestment Ratio for Zhejiang Ausun Pharmaceutical Co Ltd from 2013 to 2025. For live market cap and broader valuation context, see Zhejiang Ausun Pharmaceutical Co Ltd market capitalisation.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.67x | CN¥156.51 Million | CN¥104.45 Million | ▲ +6.7% |
| 2024 | 0.63x | CN¥177.93 Million | CN¥111.30 Million | ▼ -15.1% |
| 2023 | 0.74x | CN¥221.85 Million | CN¥163.47 Million | ▼ -67.3% |
| 2022 | 2.26x | CN¥120.57 Million | CN¥271.91 Million | ▲ +26.2% |
| 2021 | 1.79x | CN¥173.90 Million | CN¥310.85 Million | ▲ +166.3% |
| 2020 | 0.67x | CN¥138.47 Million | CN¥92.95 Million | ▲ +18.7% |
| 2019 | 0.57x | CN¥87.73 Million | CN¥49.63 Million | ▼ -88.2% |
| 2018 | 4.79x | CN¥11.50 Million | CN¥55.05 Million | ▲ +311.9% |
| 2017 | 1.16x | CN¥46.78 Million | CN¥54.36 Million | ▲ +153.1% |
| 2016 | 0.46x | CN¥93.21 Million | CN¥42.79 Million | ▼ -42.5% |
| 2015 | 0.80x | CN¥53.63 Million | CN¥42.80 Million | ▼ -25.8% |
| 2014 | 1.08x | CN¥21.45 Million | CN¥23.08 Million | ▼ -53.9% |
| 2013 | 2.33x | CN¥15.73 Million | CN¥36.71 Million | — |